ghk-cu injectable clinical trial

Biohacking culture People want to optimize performance and longevity Social media influence Peptides are widely promoted as recovery “shortcuts” Frustration with slow healing = lack of education by providers on how long tendon/ligament injuries can take to “repair” Athletes often seek ways to speed recovery beyond natural timelines A Major Concern: Unregulated Products Currently: most peptides are not approved by Health Canada or the FDA manufacturing is largely unregulated quality control is inconsistent This makes it difficult to verify: product purity dosing accuracy contamination risk Current Medical Consensus “Peptides show biological promise in preclinical research but lack sufficient human evidence for routine clinical use” Important unknowns include: dosing frequency duration long-term safety How Group23 Approaches Regenerative Medicine At Group23 Sports Medicine, we focus on treatments supported by the strongest evidence: structured rehabilitation programs under physiotherapy supervision load management and strength training – ideally with strength and conditioning coach platelet-rich plasma (PRP) soft tissue adapted biocompatible hyaluronic acid injections → SportVis – see www.sportvis.ca high molecular weight cross linked hyaluronic acid injections → Monovisc (see www.monovisc.ca), Synolis VA (see www.synolis.com) and Durolane (www.durolane.ca/en/) Blood Flow Restriction (BFR) therapy (see off the shelf and custom bracing strategies These treatments currently have far stronger clinical evidence than experimental peptide therapies https://octagonpeptides.co.uk/wp-content/uploads/2026/03/AA848FB8-AA7C-44B4-AD90-A6819DEA3FFF-600x600.jpg Weight:10 x 5mg Lab Pack 6 - Ultimate Anemia treatment BAC Water - 3 ML - PeptivaPro US